Crossmark

Efficacy and safety of Latilactobacillus sakei LB-P12 in patients with knee osteoarthritis: an exploratory randomized, double-blind, placebo-controlled clinical trial

Crossref DOI link: https://doi.org/10.1038/s41598-025-11250-0

Published Online: 2025-07-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shine, Bo-Kyung

Li, Qing

Song, Mikyung

Song, Kyoungsub

Shim, Jaeseok

Han, Seong-Ho
License Information

Text and Data Mining valid from 2025-07-17

Version of Record valid from 2025-07-17
More Information

Article History

Received: 5 February 2025

Accepted: 9 July 2025

First Online: 17 July 2025

Declarations

:

: The authors declare no competing interests.

: This study was performed in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (IRB) of the Dong-A University Hospital Institutional Review Board (DAUHIRB-EXP-23–187, 11 Sept. 2024).

: Informed consent was obtained from all the participants before their inclusion in this study.

Document is current

Any future updates will be listed below